Cutaneous manifestations of Epstein–Barr virus (EBV)-driven B-cell lymphoid proliferations occur rarely as a result of severe immunodeficiency. To date, only a few cases of extranodal EBV-associated B-cell lymphomas arising in patients with angioimmunoblastic T-cell lymphoma (AITL) have been reported, and less common is a cutaneous presentation. AITL is a rare aggressive tumor that carries a poor prognosis and prompt diagnosis, and recognition of EBV-associated diffuse B-cell lymphoma is essential in these patients to instigate the correct treatment.
*Department of Dermatology, NHS Foundation Trust, Oxford University Hospitals, Oxford, United Kingdom;
†Department of Cellular Pathology, NHS Foundation Trust, Oxford University Hospitals, Oxford, United Kingdom; and
‡Department of Haematology, NHS Foundation Trust, Oxford University Hospitals, Oxford, United Kingdom.
Correspondence: Flora Poon, Department of Dermatology, Monash Health, 246 Clayton Road, Clayton, Victoria 3168, Australia (e-mail: email@example.com).
The authors declare no conflicts of interest.